FIELD: medicine, chemical-pharmaceutical industry. SUBSTANCE: invention relates to development and production of anti-inflammatory and antibacterial drugs as ointments and aerosols. Drug has the following components, %: hydrocortisone acetate 0.25-1.75; nitazol 0.50-3.50; medicinal Vaseline oil 5.00-35.00; Tween-80 0.60-1.80; synthetic primary higher saturated alcohols of C16-C20-fraction or cetostearyl alcohol 4.00-7.60; propylene glycol 5.00-40.00, purified water up to 100% and additionally drug can contain chladon-12 at amount 15-17%. Invention provides the complex effect on damaged tissues at multidirected therapeutic effect. EFFECT: enhanced effectiveness of the drug, decreased negative adverse effects. 2 cl, 3 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
ANTI-INFLAMMATORY AND ANTIBACTERIAL DRUG FOR TOPICAL USE | 1998 |
|
RU2157214C2 |
AGENT FOR TREATMENT OF DERMATOLOGICAL DISEASES | 2001 |
|
RU2197247C2 |
ANTIINFLAMMATORY AND WOUND-HEALING DRUG | 1995 |
|
RU2116784C1 |
ANTIVIRAL AGENT "GERPEVIR" FOR TOPICAL USE | 1998 |
|
RU2138265C1 |
DERMATOLOGICAL REMEDY "MIKONAZOL" | 1998 |
|
RU2157187C2 |
COMPOSITION AND METHOD FOR PREPARING OPHTHALMIC HYDROCORTISONE OINTMENT | 2003 |
|
RU2282436C2 |
AGENT FOR INFECTED WOUNDS TREATMENT | 1991 |
|
RU2020935C1 |
AGENT FOR TREATMENT OF SUPPURATIVE-NECROTIC PROCESSES | 1998 |
|
RU2145497C1 |
ANTI-INFLAMMATORY FORMULATION AND PROCESS FOR PREPARING THE SAME | 1989 |
|
RU2008002C1 |
COMBINED PREPARATION FOR TREATING SKIN DISEASES | 2002 |
|
RU2223097C1 |
Authors
Dates
1999-09-20—Published
1998-04-16—Filed